» Articles » PMID: 31694310

Clinical Response to Personalized Exercise Therapy in Heart Failure Patients with Reduced Ejection Fraction is Accompanied by Skeletal Muscle Histological Alterations

Abstract

Heart failure (HF) is associated with skeletal muscle wasting and exercise intolerance. This study aimed to evaluate the exercise-induced clinical response and histological alterations. One hundred and forty-four HF patients were enrolled. The individual training program was determined as a workload at or close to the lactate threshold (LT1); clinical data were collected before and after 12 weeks/6 months of training. The muscle biopsies from eight patients were taken before and after 12 weeks of training: histology analysis was used to evaluate muscle morphology. Most of the patients demonstrated a positive response after 12 weeks of the physical rehabilitation program in one or several parameters tested, and 30% of those showed improvement in all four of the following parameters: oxygen uptake (VO2) peak, left ventricular ejection fraction (LVEF), exercise tolerance (ET), and quality of life (QOL); the walking speed at LT1 after six months of training showed a significant rise. Along with clinical response, the histological analysis detected a small but significant decrease in both fiber and endomysium thickness after the exercise training course indicating the stabilization of muscle mechanotransduction system. Together, our data show that the beneficial effect of personalized exercise therapy in HF patients depends, at least in part, on the improvement in skeletal muscle physiological and biochemical performance.

Citing Articles

Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms.

Cho J, Choi Y, Sajgalik P, No M, Lee S, Kim S Cells. 2020; 9(10).

PMID: 33066240 PMC: 7602002. DOI: 10.3390/cells9102284.

References
1.
Larsen A, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K . Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol. 2002; 83(1):25-32. DOI: 10.1016/s0167-5273(02)00014-1. View

2.
Springer J, Springer J, Anker S . Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017; 4(4):492-498. PMC: 5695190. DOI: 10.1002/ehf2.12237. View

3.
Dmitrieva R, Revittser A, Klukina M, Sviryaev Y, Korostovtseva L, Kostareva A . Functional properties of bone marrow derived multipotent mesenchymal stromal cells are altered in heart failure patients, and could be corrected by adjustment of expansion strategies. Aging (Albany NY). 2015; 7(1):14-25. PMC: 4350322. DOI: 10.18632/aging.100716. View

4.
Stecco A, Stern R, Fantoni I, De Caro R, Stecco C . Fascial Disorders: Implications for Treatment. PM R. 2015; 8(2):161-8. DOI: 10.1016/j.pmrj.2015.06.006. View

5.
Vescovo G . Skeletal muscle response to exercise and treatment: another sibyl in the heart failure syndrome?. Int J Cardiol. 2002; 83(1):33-4. DOI: 10.1016/s0167-5273(02)00015-3. View